Type 2 & other diabetes

Clinical relevance of coronary risk classification and reclassification with coronary artery calcium score in asymptomatic people living with diabetes. An observational study

Diabetes MetabPublished Retrospective observational study

Authors' conclusion

Following national guidelines, 66% of our population of asymptomatic diabetic persons at high a priori coronary risk were reclassified into the moderate risk category, translating into less stringent goals for risk factor control. Eighteen percent were reclassified into the very high-risk category, leading to 100% detection sensitivity for patients with ischemia and coronary stenoses.

Study context

Population
Asymptomatic primary prevention diabetic patients at high or very high a priori coronary risk per national guidelines; all had coronary artery calcium (CAC) score and stress myocardial scintigraphy, coronary angiography if ischemia
Participants
377 patients
Exposure
Coronary risk classification a priori vs after CAC-reclassification for selecting patients for ischemia screening
  • High a priori riskn = 242
  • Very high a priori riskn = 135
Outcome
CAC-reclassification of patients at high a priori risk

Main finding

As reported in the abstract

Reclassified to moderate risk

n = 159, 66%

Remained high risk

n = 38

Reclassified to very high risk

45 patients

Observational data: associations, not effects.

Further findings

Myocardial ischemia and coronary stenoses detected (whole cohort)

Myocardial ischemia
35 patients
Coronary stenoses among those with ischemia
14

Screening only patients at very high a priori risk (n=135)

Ischemia detected
18 patients (sensitivity 51%)
Coronary stenoses detected
9 (sensitivity 64%)

Additional screening of 45 patients at very high risk after CAC-reclassification

Additional patients with ischemia
7
Additional patients with coronary stenoses
5

Original publication

Clinical relevance of coronary risk classification and reclassification with coronary artery calcium score in asymptomatic people living with diabetes. An observational study. Diabetes Metab. Published 20 November 2022. doi:10.1016/j.diabet.2022.101412

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.